2008
DOI: 10.1016/j.jinf.2007.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Streptococcus agalactiae in pregnant women: Phenotypic and genotypic characters

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
24
1
1

Year Published

2010
2010
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(39 citation statements)
references
References 32 publications
13
24
1
1
Order By: Relevance
“…This was the motivation for this study involving Even considering the different rates of GBS infection according to the methodological approach used in this study, 9.5% and 32.6%, both values of prevalence are in agreement with literature data, which point to a prevalence range of 3-41% (13,26,27,32,33,35). This worldwide variability is related to different sociocultural, geographic, climatic, biological and methodological determinants.…”
Section: Discussionsupporting
confidence: 82%
See 1 more Smart Citation
“…This was the motivation for this study involving Even considering the different rates of GBS infection according to the methodological approach used in this study, 9.5% and 32.6%, both values of prevalence are in agreement with literature data, which point to a prevalence range of 3-41% (13,26,27,32,33,35). This worldwide variability is related to different sociocultural, geographic, climatic, biological and methodological determinants.…”
Section: Discussionsupporting
confidence: 82%
“…Nine distinct serotypes are recognized as part of the human microbiota colonizing mucous membranes, especially the gastrointestinal and genitourinary tracts (7,27). In the 70`s GBS was recognized as the main etiology of early-onset neonatal sepsis, with evidence pointing to vertical transmission (mother-to-infant), chiefly by contact with and aspiration of vaginal secretions from the colonized birth canal during labor (21,28).…”
Section: Lancefield Group B Streptococcus (Gbs) Ormentioning
confidence: 99%
“…This is in line with previous findings in the Asia, Europe and the United States (Table 1 [ [6][7][8][9][10][11][12][13][14][15][16][17][18][19]). In the study by Morozumi et al [2], 7/32 (21·9%) serotype Ia and 24/88 (27·3%) serotype III GBS isolates showed ML resistance.…”
Section: Association Between Capsular Serotype V and Macrolide Resistsupporting
confidence: 93%
“…[4,5] To treat GBS infection, penicillin, ampicillin, and cefazolin are the drugs of choice; for patients allergic to penicillin or cephalosporins, vancomycin, macrolides (such as erythromycin, azithromycin, and clarithromycin), and lincosamides (clindamycin) may be used as the alternative drugs. [6][7][8][9] Vancomycin resistance has not been reported in GBS.…”
Section: S Treptococcus Agalactiae (Group B Streptococcus Gbs)mentioning
confidence: 99%